AMAR .19 -- for anyone interested, a previously released interview with lead scientist on Perth, Australia clinical study wrapping up currently. Radio interview gives easy to follow synopsis on the history and current use of low dose interferon alpha for prevention of cold and flu:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.